By Research Area
Hot products 
-
Mouse Anti-DES Monoclonal Antibody (440) (CBMAB-AP1857LY)
-
Mouse Anti-CIITA Recombinant Antibody (CBLC160-LY) (CBMAB-C10987-LY)
-
Mouse Anti-ALB Recombinant Antibody (V2-55272) (CBMAB-H0819-FY)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-ATP1B3 Recombinant Antibody (1E9) (CBMAB-A4021-YC)
-
Mouse Anti-DLC1 Recombinant Antibody (D1009) (CBMAB-D1009-YC)
-
Mouse Anti-CCT6A/B Recombinant Antibody (CBXC-0168) (CBMAB-C5570-CQ)
-
Mouse Anti-BCL6 Recombinant Antibody (CBYY-0442) (CBMAB-0445-YY)
-
Human Anti-SARS-CoV-2 S1 Monoclonal Antibody (CBFYR-0120) (CBMAB-R0120-FY)
-
Mouse Anti-AFM Recombinant Antibody (V2-634159) (CBMAB-AP185LY)
-
Mouse Anti-ADAM12 Recombinant Antibody (V2-179752) (CBMAB-A1114-YC)
-
Mouse Anti-HTLV-1 gp46 Recombinant Antibody (CBMW-H1006) (CBMAB-V208-1154-FY)
-
Rat Anti-EPO Recombinant Antibody (16) (CBMAB-E1578-FY)
-
Armenian hamster Anti-CD40 Recombinant Antibody (HM40-3) (CBMAB-C10365-LY)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Rabbit Anti-ABL1 (Phosphorylated Y185) Recombinant Antibody (V2-443434) (PTM-CBMAB-0001YC)
-
Mouse Anti-ALDOA Recombinant Antibody (A2) (CBMAB-A2316-YC)
-
Mouse Anti-CORO1A Recombinant Antibody (4G10) (V2LY-1206-LY806)
-
Rabbit Anti-ATF4 Recombinant Antibody (D4B8) (CBMAB-A3872-YC)
-
Mouse Anti-CD24 Recombinant Antibody (ALB9) (CBMAB-0176CQ)
Immunology Research
Immunology explores the molecular and cellular networks that enable organisms to distinguish self from non-self, neutralize pathogens, and maintain tissue homeostasis. The immune system comprises innate and adaptive branches, each with specialized roles. Innate immunity provides immediate, nonspecific defense via phagocytes, complement proteins, and cytokines, while adaptive immunity delivers antigen-specific responses mediated by T and B lymphocytes. Central to this duality is antigen presentation, wherein dendritic cells process and display foreign peptides to activate T cells, initiating targeted effector functions such as antibody production or cytotoxic killing.
When immune regulation fails, pathologies emerge. Autoimmune disorders arise from aberrant self-antigen recognition, as seen in rheumatoid arthritis or lupus. Allergic hypersensitivity involves excessive IgE-mediated responses to innocuous antigens, while immunodeficiencies compromise host defense, increasing susceptibility to infections. Chronic inflammation, driven by unresolved immune activation, underpins conditions like inflammatory bowel disease and atherosclerosis. Key molecular mediators—cytokines (e.g., IL-6, TNF-α), chemokines, and immune checkpoints (e.g., PD-1, CTLA-4)—orchestrate these processes, making them pivotal therapeutic targets.
Advancing immunology research hinges on dissecting signaling pathways and cellular interactions at high resolution. Technologies such as single-cell sequencing has illuminated mechanisms of immune evasion in cancer and infection. Novel modalities like monoclonal antibodies, CAR-T cells, and checkpoint inhibitors exemplify translational successes derived from foundational discoveries.
Creative Biolabs provides rigorously validated antibody reagents tailored for immunological research. Our portfolio includes antibodies targeting cytokines, immune cell markers, and signaling proteins, optimized for flow cytometry, immunohistochemistry, and functional assays. Each product undergoes stringent specificity and reproducibility testing to ensure reliability in deciphering immune mechanisms. By delivering precision tools, we empower researchers to accelerate breakthroughs in understanding and modulating immune responses.
Loading...
Compare
